COVID-19 managed with early non-invasive ventilation and a bundle pharmacotherapy: A case report
| Autor: | Yong-Feng Liu, Yansi Lyu, Jin-xiu Li, Xue-yan Liu, Mian Peng, Xi Meng, Bao-Jun Yu, Rong-Lin Chen, Di Ren |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2020 |
| Předmět: |
2019-20 coronavirus outbreak
medicine.medical_specialty Coronavirus disease 2019 (COVID-19) business.industry Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Case Report General Medicine medicine.disease medicine.disease_cause law.invention 03 medical and health sciences Pneumonia 0302 clinical medicine Pharmacotherapy law 030220 oncology & carcinogenesis Bundle Ventilation (architecture) medicine 030211 gastroenterology & hepatology business Intensive care medicine Coronavirus |
| Zdroj: | World J Clin Cases |
| Popis: | BACKGROUND: The coronavirus disease 2019 (COVID-19) pandemic has become an immense public health burden, first in China and subsequently worldwide. Developing effective control measures for COVID-19, especially measures that can halt the worsening of severe cases to a critical status is of urgent importance. CASE SUMMARY: A 52-year-old woman presented with a high fever (38.8 °C), chills, dizziness, and weakness. Epidemiologically, she had not been to Wuhan where COVID-19 emerged and did not have a family history of a disease cluster. A blood test yielded a white blood cell count of 4.41 × 10(9)/L (60.6 ± 2.67% neutrophils and 30.4 ± 1.34% lymphocytes). Chest imaging revealed bilateral ground-glass lung changes. Based on a positive nasopharyngeal swab nucleic acid test result and clinical characteristics, the patient was diagnosed with COVID-19. Following treatment with early non-invasive ventilation and a bundle pharmacotherapy, she recovered with a good outcome. CONCLUSION: Early non-invasive ventilation with a bundle pharmacotherapy may be an effective treatment regimen for the broader population of patients with COVID-19. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|